BTSG BrightSpring Health Service...

Nasdaq www.brightspringhealth.com


$ 32.59 $ -0.49 (-1.49 %)    

Tuesday, 04-Nov-2025 15:16:08 EST
QQQ $ 620.49 $ -2.76 (-0.44 %)
DIA $ 470.89 $ 0.53 (0.11 %)
SPY $ 676.03 $ -0.10 (-0.01 %)
TLT $ 89.94 $ 0.15 (0.17 %)
GLD $ 362.09 $ -1.50 (-0.41 %)
$ 33.49
$ 32.98
$ 32.59 x 526
$ 32.61 x 100
$ 32.33 - $ 33.78
$ 15.26 - $ 35.01
2,514,989
na
6.04B
$ 0.96
$ 46.61
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-02-2025 03-31-2025 10-Q
4 03-06-2025 01-01-1970 10-K
5 11-01-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-brightspring-health-raises-price-target-to-41

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $30 to $41.

 ubs-maintains-buy-on-brightspring-health-raises-price-target-to-42

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $35 to $42.

 brightspring-health-raises-fy2025-sales-guidance-from-12400b-12700b-to-12500b-12800b-vs-12536b-est

BrightSpring Health (NASDAQ:BTSG) raises FY2025 sales outlook from $12.400 billion-$12.700 billion to $12.500 billion-$12.800 b...

 brightspring-health-q3-adj-eps-030-misses-032-estimate-sales-3334b-beat-3308b-estimate

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of...

 reported-earlier-brightspring-prices-15m-share-secondary-offering-with-concurrent-15m-share-buyback-at-underwriter-purchase-price

BrightSpring. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the procee...

 brightspring-health-raises-fy2025-sales-guidance-from-12200b-12600b-to-12400b-12700b-vs-12509b-est

BrightSpring Health (NASDAQ:BTSG) raises FY2025 sales outlook from $12.200 billion-$12.600 billion to $12.400 billion-$12.700 b...

 brightspring-health-services-announces-secondary-offering-of15m-shares-by-existing-stockholders-company-to-repurchase-up-to-50m-of-shares

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"), a leading provider of home ...

 brightspring-health-sees-prelim-q3-adj-eps-030-vs-027-est-sees-sales-3334b-vs-3167b-est

BrightSpring Health (NASDAQ:BTSG) is looking for Prelim  Q3 Adj EPS of $0.30 vs $0.27 analyst estimate. sees sales of $3.334 bi...

 mizuho-maintains-outperform-on-brightspring-health-raises-price-target-to-32

Mizuho analyst Ann Hynes maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $26 ...

Core News & Articles

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251014-1480342/1480342_vbtx6.pdf

 morgan-stanley-maintains-overweight-on-brightspring-health-raises-price-target-to-32

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price targe...

 ubs-maintains-buy-on-brightspring-health-raises-price-target-to-35

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $31 to $35.

 wells-fargo-maintains-overweight-on-brightspring-health-raises-price-target-to-33

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target...

 b-of-a-securities-maintains-buy-on-brightspring-health-raises-price-target-to-31

B of A Securities analyst Joanna Gajuk maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target fr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION